CUPR CUPR
Company Profile ↓Company Overview
CUPR (CUPR) is a publicly traded company listed on with a market capitalization of $9.60M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.10.
Recent Developments
- Dec 2025 Revenue of $49.89K (+3.3% YoY); net profit $-4.67M.
- Trailing 12 Months Year-on-year growth — revenue +3.3%.
- 5-Year Trend Long-term compounding — revenue CAGR -4.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -4.12% |
| 1 Year: | 3.26% |
Stock Price Performance
| 1 Year: | -94.88% |
| 6 Months: | +2.87% |
| 3 Months: | +68.23% |
| 1 Month: | -37.63% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Golden Cross2d ago
- RSI (14)48.49 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -4.1% CAGR over 5 years.
- Trading 95.2% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 56.60K | 100.77K | 48.32K | 49.89K |
| Cost of Revenue | - | 36.62K | 64.17K | 51.34K | 50.54K |
| Gross Profit | - | 19.98K | 36.60K | -3.02K | -645 |
| Operating Expenses | - | 1.14M | 1.07M | 1.48M | 4.57M |
| Operating Income | - | -1.12M | -1.03M | -1.48M | -4.57M |
| EBITDA | - | -1.06M | -994.12K | -1.43M | -4.56M |
| Interest Expense | - | 2.02K | 56.59K | 37.21K | 14.72K |
| Pretax Income | - | -1.09M | -1.09M | -1.51M | -4.61M |
| Tax Provision | - | 0 | 0 | 0 | 0 |
| Net Income | - | -1.09M | -1.12M | -1.56M | -4.67M |
| Diluted EPS | -0.20 | -0.42 | -0.41 | -0.57 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.44M | 1.59M | 1.75M | 8.50M |
| Current Assets | - | 1.27M | 1.44M | 1.66M | 7.33M |
| Cash & Equivalents | - | 564.58K | 35.26K | 116.47K | 3.12M |
| Inventory | - | 6.50K | 7.67K | 1.73K | 0 |
| Receivables | - | 41.72K | 50.82K | 26.39K | 18.22K |
| Total Liabilities | - | 3.21M | 4.48M | 6.20M | 3.45M |
| Current Liabilities | - | 3.09M | 4.43M | 6.04M | 3.12M |
| Long Term Debt | - | 43.17K | 21.70K | 163.73K | 126.20K |
| Total Debt | - | 183.63K | 121.82K | 254.79K | 482.72K |
| Total Equity | - | -1.78M | -2.90M | -4.46M | 5.06M |
| Shares Outstanding | - | 2.72M | 2.72M | 2.72M | 2.68M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.85M | -894.98K | -1.24M | -9.13M |
| Investing Cash Flow | - | -31.28K | -67.98K | -21.88K | -58.23K |
| Financing Cash Flow | - | 1.68M | 433.07K | 1.34M | 12.23M |
| Capital Expenditure | - | -16.05K | -67.98K | -21.88K | -58.23K |
| Free Cash Flow | - | -1.87M | -962.96K | -1.26M | -9.19M |
| Net Change in Cash | - | -202.46K | -529.88K | 83.11K | 3.04M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 35.3% | 36.3% | -6.3% | -1.3% |
| Operating Margin % | - | -1,987.2% | -1,021.8% | -3,061.7% | -9,154.6% |
| Net Margin % | - | -1,933.8% | -1,111.0% | -3,229.5% | -9,366.8% |
| ROE % | - | 61.5% | 38.6% | 35.0% | -92.4% |
| ROCE % | - | 67.9% | 36.3% | 34.4% | -84.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CUPR
Cuprina Holdings (CUPR) Stock Forum and Discussion - Moomoo
<a href="https://news.google.com/rss/articles/CBMipAJBVV95cUxNNUpfbXJVYTZWNnkwOV9GTXFuUkpMcnVVeU1ZeVFvNkVmMDhLam5ZWTNpLVpoSDRFME5MMFVyNzJxUG5EX0p4SnZBb0xZT2ZhMk9seHcwQ2NRS3JnRGNzYXZEWGhmRDlCZVlIdGNkSTBfM0JEeVhrNUc0WFpERS1DNE0xWkxmbGFuNDhaTH…
Cuprina Holdings Falls 22% After 112% Rally — Here's Why CUPR Stock Is Trending - Benzinga
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxPOE1JYnd4eWt4em9GRlJucmhpVDlCZ1hCYmFyLUhFS25HSHJ1bjY0SUNOem9qVTVWRVM1RW9sdmJDVFkzNWVpU3o2NlN0OXhNR05UTTdSLWNNdzB1SlpCQmVFTV9zZThIb1dzYlRSclBqa3RpZk9fMUxpOUhTRjJrNVlDV2NkOXdJQUtncj…
CUPR Stock Ignites As Traders Pile Into Momentum Spike - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOajJ2UGZjS0V0eHhDdFBDZ0hRdkV2am1fV2UtQXJvOTItVGd0TVc0ajVDdW5aZ0pwOTdqSmRlSGQ5LTU0bXF0WGFyd1h5MzgzdHFkT1EyeFY1OFpPbXJHRHZZSFN0QVBtdExabmFIaTJMZTJjMTFBSjZ1cUNKcUF4RUlfOW1QWDhCR0tLQQ…
Why Did CUPR Stock Surge Over 150% Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxON0tjd2NTQXVPNlQxWXVlb0h6RW43SXFUdGUtSzU1dlE5Rmx2SjRoNXp2U1JNNU50Y1lhRy1nalNORkc2bHBVSnVHMHB6QkQ5QWI5cnIySGNKZzZ5QkpTSlp5SlZKMzI4SWp1Nm5TZzJCbmJMSlByQVBlcE9OYU4zWVRPS1hRLXFLZmJ4b1…
FDA clears Cuprina's live maggots to remove dead tissue from chronic wounds - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOeTM4cFpOVG9idXkwaXh2YldZQzJ4cDZDRzF1LWFjT05CVjFISnh5UXdFUjA2cmw3bDl0ZzJQMDdkZVprS0QtMTZxYXRwaXI4dnJaX1lIZHpJSHJNQlFjN2ZfV1Zfd09vcHhRaFBnTFpRZUVMTE5VYXJ5ODRVN0RGZG1SX1Q4OEFLRGZ4NG…
Cuprina Holdings Rallies as Traders Revisit Recent FDA Clearance and Nasdaq Compliance Update - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQdVh5bzRPQWZWRmxSd2kyNFpuTHEzQzRsZ2ltQ01sSkw1bEtka0QwWjhFNW9RUGhERTJheGFJMXBNb0VIcHlFd0tzRktwdXhwY2UzdVlIUFlBYmhnb05oZWsxRGZUNnc0Vngwb3ZadE85YlEzWkVaNVB0eUxkOFk3cEEyam9wclBrN082Vk…
CUPR — Frequently Asked Questions
What is the current share price of CUPR?
As of 2026-08-05 17:25 PDT, CUPR trades at $3.58 on NASDAQ/NYSE. Its 52-week range is $1.96 to $75.20.
What is the market capitalisation of CUPR?
CUPR has a market capitalisation of $9.60M on NASDAQ/NYSE.
What is the P/E ratio of CUPR?
CUPR trades at a trailing price-to-earnings (P/E) ratio of -6.24. Its price-to-book (P/B) ratio is 1.90.
What is the return on equity (ROE) of CUPR?
CUPR has a return on equity (ROE) of -92.44%. Its return on capital employed (ROCE) is -84.76%.
Is CUPR a good stock to buy?
This page provides a data-driven analysis of CUPR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.